Man

Jaime Pereira Garcés

Jefe

ESCUELA DE MEDICINA, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

Líneas de Investigación


PLATELETS PHYSIOLOGY, PATHOPHYSIOLOGY, MOLECULAR BIOLOGY AND NATIVE IMMUNITY THROMBOTIC DISEASES PATHOPHYSIOLOGY; VASCULAR DAMAGE ASSOCIATED TO COCAINE USE; ENDOTHELIAL DYSFUNCTION; PLATELETS AND ENDOTHELIUM IN THROMBOSIS AND HAEMOSTASIA

Educación

  •  Licenciate in medicine, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1977
  •  Medical Doctor, UNIVERSIDAD DE CHILE. Chile, 1978
  •  HEMATOLOGY, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1984
  •  FOGARTY INT RESEARCH FELLOWSHIP NIH, Blood Center of SE Wisconsin. Estados Unidos, 1987

Experiencia Académica

  •   Full Professor Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicine

    Santiago, Chile

    1984 - A la fecha

  •   Director, Doctorate in Medical Sciences Program Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicine

    Santiago, Chile

    2013 - 2018

  •   Director of Research Full Time

    Medicine

    Santiago, Chile

    2000 - 2004

  •   Jefe Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Chile

    2018 - A la fecha

Experiencia Profesional

  •   HEAD OF BLOOD BANKING Full Time

    CLINICAL HOSPITAL, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Santiago, Chile

    1997 - 2018

  •   STAFF MD, BLOOD BANK, HEMATOLOGY DEPARTMENT Full Time

    CLINICAL HOSPITAL, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    SANTIAGO, Chile

    1984 - 1997

  •   Jefe Full Time

    Red de Salud UC-Christus, Pontificia Universidad Católica de Chile, Laboratorio de Trombosis y Hemostasia

    Santiago, Chile

    2018 - A la fecha

  •   Jefe Full Time

    Pontificia Universidad Católica de Chile, Escuela de Medicina, Departamento de hematología-Oncología

    Chile

    2018 - A la fecha

Formación de Capital Humano


In the Blood Bank : undergraduate medical and tecnology studentss
postgraduate rmedical residents from Hematology programme 5/year during 1 month
students fron doctorate in medical sciences

1993 - : Director Tesis de Magíster en Ciencias, Mención Inmunología, Universidad de Chile. "Especificidad antigénica de los anticuerpos antiplaquetarios en pacientes portadores de lupus eritematoso sistémico". Alumno. Iván Palomo G

1994 - 1995 : Dirección de Investigación Escuela de Medicina Concurso de Becados "Trombocitopenia inducida por heparina: pesquisa

1998 - : Director de Tesis de Doctorado en Ciencias Biomédicas, Universidad de Chile. "Estudio de los mecanismos inmunes y no inmunes, que participan en la remoción de las plaquetas de la circulación". Alumno. Iván Palomo G.

1999 - : Director de Tesis de Magister en Ciencias, Mención Inmunología,Universidad de Chile. "Características de la aloinmunización transplacentaria a antígenos plaquetarios específicos y antígenos HLA clase I". Alumna: Mónica Soto S.de anticuerpos anti-complejo PF4-heparina y estudio de su efecto funcional sobre las plaquetas" Tutor

2003 - 2005 : Director de Tesis de Pregrado para optar al título de Bioquímico: "Caracterización de micropartículas circulantes y su papel en la patogenia del estado protrombótico en el lupus eritematoso sistémico. Alumno: Gino Alfaro A.

Ene 1998 - Feb 1998 : Dirección de Investigación. Tutor Programa de Inmersión en un Laboratorio de Investigación Proyecto: "Determinación de anticuerpos ant-CD36 en pacientes con lupus eritematoso sistémico. Alumna: María Inés Brugal S.

Ene 1999 - : Dirección de Investigación.Tutor Programa de Inmersión en un Laboratorio de Investigación Proyecto: "Factores genéticos de riesgo de trombosis en pacientes con fibrilación auricular y embolía sistémica" Alumna: Gianella Caiozzi

Ene 2001 - : Dirección de Investigación.Tutor Programa de Inmersión en un Laboratorio de Investigación Proyecto: "Muerte celular programada en las plaquetas de los pacientes con lupus eritematoso sistémico" Alumno: Sebastián Ibañez V.

Ene 2002 - : Dirección de Investigación.Tutor Programa de Inmersión en un Laboratorio de Investigación Proyecto:"Variabilidad en la expresión clínica de la Enfermedad de von Willebrand: estudio sobre el efecto modulador del nivel de glicoproteína VI en las plaquetas" Alumna: María Elisa Pereira M.

Mar 1998 - Dic 1998 : Dirección de Investigación.Tutor Programa especial de Ayudantes-alumnos Proyecto: "Cambios asociados al envejecimiento in vitro de las plaquetas y su papel como determinantes de la supervivencia post-transfusión" Alumnas: Javiera Martínez G y Viera Morales M.

Mar 1999 - Mar 2000 : Dirección de Investigación.Tutor Programa especial de Ayudantes-alumnos Proyecto: "Pérdida de la asimetría de fosfolípidos de membrana en plaquetas almacenadas para transfusión ¿Constituye un marcador de apoptosis? Alumnas: Javiera Martínez G y Viera Morales M.

Mar 2000 - Mar 2001 : Dirección de Investigación.Tutor Programa especial de Ayudantes-alumnos Proyecto: "Pérdida de la asimetría de fosfolípidos de membrana de las plaquetas: paple en la trombocitopenia del lupus eritematoso sistémico y del sindrome antifosfolípido" Alumno: Smiljan Astudillo M.

Mar 2001 - Mar 2002 : Dirección de Investigación.Tutor Programa especial de Ayudantes-alumnos Proyecto:"Fibrilación auricular y trombosis: Papel de factores de riesgo genéticos" Alumno: Sebastián Ibañez V.


Premios y Distinciones

  •   Premio Dr. German Ducach al mejor trabajo clínico de hematología publicado

    Sociedad Médica de Santiago

    Chile, 2001

    Glycoprotein Ib/IX complex is the target in rifampicin-induced immune thrombocytopenia. Pereira J, Hidalgo P, Ocqueteau M, Blacutt M, Marchesse M, Nien Y, Letelier L, Mezzano D. Br J Haematol. 2000 Sep;110(4):907-10. mio

  •   premio al mejor trabajo científico

    IX Congreso Chileno de Nefrología

    Chile, 1991

    Estudio de la naturaleza antigénica de los complejos inmunes detectados en la forma clásica del sindrome hemolítico urémico" Olavarría F, Pereira J, Mezzano S, Kunick M, Castillo A.

  •   Premio al mejor trabajo clínico epidemiológico

    XXIV Congreso Chileno de Enfermedades Respiratorias

    Chile, 1991

    Sellamiento pleural terapéutico con fibrina" Aparicio R, Pereira J, Erskine P, Cid P.

  •   Premio Dr. Germán Ducach al mejor trabajo clínico de hematología publicado

    Sociedad Médica de Santiago

    Chile, 2003

    Mediterranean diet but not red wine, is associated with beneficial changes in primary hemostasis. Mezzano D, Leighton F, Strobel P, Martínez C, Marshall G, Cuevas A, Castillo O, Panes O, Muñoz B, Rozowski J, Pereira J.Eur J Clin Nutr 2003; 57: 439-446.

  •   Premio Dr. Germán Ducach otorgado por la al mejor trabajo clínico de hematología publicado

    Sociedad Médica de Santiago

    Chile, 2005

    Template bleeding time and PFA-100Ò have low sensitivity to screen patients with mucocutaneous haemorrhages of hereditary nature: comparative study in 148 patients. Quiroga T, Goycoolea , Muñoz B, Morales M, Aranda E, Panes O, Pereira J, Mezzano D. J Thromb Haemostas 2004; 2: 892-898

  •   Premio al mejor trabajo

    XXIX Congreso Chileno de Medicina Interna

    Chile, 2007

    Defectos de perfusion cerebral se asocian a activación del sistema hemostático en usuarios crónicos de cocaína. Massardo T, Jaimovich R, Pallavicini J, Quintana JC, Panes O, Hidalgo P, Mezzano D, Pereira J . Santiago, Septiembre 2007

  •   Premio al Mejor Trabajo Libre

    XVI Congreso Chileno de Hematología

    Chile, 2008

    Disfunción endotelial y activación del sistema hemostático en usuarios crónicos de cocaína: asociación con defectos de perfusión cerebral. Pereira J, Sáez CG, Olivares P, Moreno N, Panes O, Hidalgo P, Massardo T. Coquimbo, Septiembre, 2008

  •   Premio al Mejor Trabajo Libre de Chile,

    XXII Congreso de Alasbimn asociación latinoamericana de sociedades de biologia y medicina nuclear

    Colombia, 2009

    Massardo T, Quintana JC, Jaimovich R, Pallavicini J, Servat M, Ibañez C, Alliende I, Niklitschek S, Alay R, Pereira J. Basal brain perfusion defects and neurocognitive dysfunction in chronic cocaine users. Cartagena de Indias, Colombia 5 al 7 de noviembre de 2009. Alasbimn Journal 2009; 12: AJ45-5.

  •   Premio al mejor trabajo clínico chileno presentado a Congreso de la Federación Mundial de Medicina Nuclear

    Sociedad Chilena Medicina Nuclear

    Chile, 2014

    CHANGES IN ABNORMAL BRAIN DEACTIVATION AFTER ONE MONTH OF COCAINE ABSTINENCE IN DEPENDENT PATIENTS PERFORMING EXECUTIVE TASKS. JC Quintana, T Massardo, R Jaimovich, C Ibáñez, J Véliz, J Pallavicini, P Flores, R Chandía, G Castro, R Fernández, M. Servat, J Pereira.


 

Article (68)

Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression.
Human platelet interaction with E-coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4
Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin.
[Evaluation of oral anticoagulation with rivaroxaban, in patients with new onset non valvular atrial fibrillation].
Changes in Regional Cerebral Blood Flow Are Associated With Endothelial Dysfunction Markers in Cocaine-Dependent Patients Under Recent Abstinence
Increased RhoA/Rho-Kinase Activity and Markers of Endothelial Dysfunction in Young Adult Subjects with Metabolic Syndrome
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells
Serum lipid levels in a group of cocaine dependent subjects in recent abstinence
Atorvastatin Reduces the Proadhesive and Prothrombotic Endothelial Cell Phenotype Induced by Cocaine and Plasma From Cocaine Consumers In Vitro.
Blood component usage during extracorporeal membrane oxygenation: experience in 98 patients at a Latin-American tertiary hospital
Diagnosing type 1 von Willebrand disease: good for patient's health or for doctor's prestige?: comment.
Inhibition of Platelet Activation and Thrombus Formation by Adenosine and Inosine: Studies on Their Relative Contribution and Molecular Modeling
Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease
An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families
Protective Mechanisms of S. lycopersicum Aqueous Fraction (Nucleosides and Flavonoids) on Platelet Activation and Thrombus Formation: In Vitro, Ex Vivo and In Vivo Studies
Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation
Clot lysis time in platelet-rich plasma: Method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid
Cocaine-induced vascular damage. Report of one case
Aortic Stenosis and Acquired von Willebrand Disease: Lack of Association
Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users
Platelet activation in chronic cocaine users: Effect of short term abstinence
Daño endotelial y activación del sistema hemostático asociado al uso crónico de cocaína: estudios ex vivo e in vitro
Influence of the F12-4 C > T polymorphism on hemostatic tests
Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays
Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause
Platelet Tissue Factor: Fast and Specific Clotting Activation Pathway Mediated by VWF-GPIba Interaction and Platelet Membrane FVII. Human Platelets Contain All the Components for Assembling the Prothrombinase Complex and Their Procoagulant Function Is Ind
Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages
Laboratory Assessment of Familial, Nonthrombocytopenic Bleeding: A Definitive Not Possible Mucocutaneous Diagnosis Is Often Not Possible
Thrombotic thrombocytopenic purpura. Experience in 18 cases and literature review
Tissue factor storage, synthesis and function in normal and activated human platelets
High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls
Human platelets synthesize and express functional tissue factor
Val/Leu(247) and Trp/Ser(316) polymorphisms in beta(2) glycoprotein I and their association with thrombosis in unselected Chilean patients
C-reactive protein and atrial fibrillation: Evidence for the presence of inflammation in the perpetuation of the arrhythmia"
Circulating platelet-derived microparticles in systemic lupus erythematosus - Association with increased thrombin generation and procoagulant state
Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis
Indications, adverse effects and results of plasmapheresis in critical care patients
Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals
Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis
Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis
Template bleeding time and PFA-100 (R) have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients
GUTI: a new antigen in the Cromer blood group system
Mediterranean diet, but not red wine, is associated with beneficial changes in primary haemostasis
Platelet membrane glycoprotein polymorphisms do not influence the clinical expressivity of von Willebrand disease type I
Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients
Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucoputaneous haemorrhages
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa
Anti phospholipid antibodies in Chilean patients with systemic lupus erythematosus
Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica
Hypercoagulable state in atrial fibrillation and its relationship with risk factors for systemic embolism
Platelet aging in vivo is associated with activation of apoptotic pathways: Studies in a model of suppressed thrombopoiesis in dogs
Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors
Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: relationship with systemic inflammation and haemostatic activation
Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia
Cardiovascular risk factors in vegetarians: Normalization of hyperhomocysteinemia with vitamin B-12 and reduction of platelet aggregation with n-3 fatty acids
Glycoprotein Ib/IX complex is the target in rifampicin-induced immune thrombocytopenia
Platelet aging in vivo is associated with loss of membrane phospholipid asymmetry.
Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure
Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine.
[Skin and mucous membrane hemorrhages: clinical assessment, study sequence and relative frequency of hereditary diseases of the hemostasis in a Chilean population].
Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure
[Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
[Hemophilia A: analysis of intron 18 and intron 7 of factor VIII gene and their role in a diagnostic strategy for carrier detection in a Chilean population].
Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
Human intraplatelet 5-hydroxytryptamine is correlated with mean platelet survival time
Sex-related difference in plasma von Willebrand factor (vWF:Ag and vWF:RiCof) levels in adolescents.
[Diagnosis of von Willebrand's disease subtypes by the analysis of multimeric composition of plasma von Willebrand factor].
Total sialic acid in human and canine platelets does not change with the platelet age.

Abstract (35)

GPIb alpha activation mediates platelet tissue factor (TF) phosphorylation, transfer to lipid rafts (LR) and activity. TFPI and protein S, released by other agonists, would assemble the inhibitory complex (TF/FVIIA/TFPI/PS) in LR, dampening FXA activity
Hemostatic disorder of uremia: patients with terminal chronic renal failure (CRF) have increased platelet tissue factor derived intravascular clotting activation with delayed clot lysis time in platelet rich plasma (CLT-PRP)
Inhibition of RhoA-RHO kinase pathway attenuates cocaine-induced microvascular endothelial cell dysfunction: studies under static and shear flow conditions
Revisiting the hemostatic disorder of uremia: patients on peritoneal dialysis (CRF-PD) have normal platelet aggregation and secretion but increased platelet tissue factor activity (TF-PCA), probably the cause of intravascular clotting activation
GPIb alpha Activation Triggers Platelet Tissue Factor/FVIIa-Dependent Procoagulant Activity, Which Is Dampened By Platelet Secreted TFPI and Protein S. Novel Platelet-Based Model of Hemostasis
Interaction of Human Platelets with Enterohemorrhagic E. coli O111, Induces an Increase in the Procoagulant Activity, Thrombin Generation and Adhesion to Endothelial Cells
Role of Sigma-1 Receptor in Cocaine-Induced Endothelial Cell Damage
Association between endothelial dysfunction markers and regional cerebral blood flow (rCBF) changes in cocaine dependent patients under recent abstinence.
Cocaine induces oxidative stress and decreased nitric oxide production in human endothelial cells: beneficial effect of atorvastatin
Increased total platelet TFPI and higher surface expression of TFPI in activated platelets may be involved in the pathogenesis of mild bleeding disorders (MBD) of undefined cause (BUC)
Inherited mild bleeding disorders (MBD) of undefined cause (BUC): platelets express decreased tissue factor-dependent FXa generation and low thrombin generation in platelet-rich plasma
NHLBI guidelines and the percentile 2.5th of plasma VWF for the diagnosis of type 1 VWD. Comparison in 4517 referred patients and 280 selected patients with conclusive bleeding history
Relation between the mechanism of antiplatelet action of adenosine from Solanum lycopersicum and its derivate inosine
Cocaine-Induced Endothelial Dysfunction: Role of RhoA/Rho Kinase Pathway Activation
Statins do not correct hypofibrinolysis in hypercholesterolemia. correcting LDL-cholest unveils an inverse relation of HDL-cholest and clot lysis time
EVALUATION OF CLOT LYSIS TIME WITH PLATELETS: CORRELATION WITH CARDIOVASCULAR RISK MARKERS
Human Platelets Express Functional Pannexin-1
Tissue factor pathway inhibitor (TFPI) and tissue factor (TF) co-localize in lipid rafts of platelet membranes: mechanism to inhibit platelet procoagulant (PCA) activity?
Clot lysis time (CLT) of PRP and PPP in hypercholesterolemia. Effect of atorvastatin and relationships with inflammatory markers
Effect of Short-Term Abstinence on Cocaine-Induced Endothelial Dysfunction and Platelet Activation
Platelet Tissue Factor Activity In Patients with Hypercholesterolemia: Modulation of Procoagulant Activity by Statins
Evidence of Endothelial Dysfunction in Cocaine Users
Platelet Tissue Factor: Expression of Pro-Coagulant Activity depends on Gpib alpha Activation and Signaling through Lyn-Mediated Phosphorylation. A Platelet-Based Model of Hemostasis
Human platelet tissue factor is localized in lipid rafts and is associated with GPIb-IX-V complex in the membrane: Association between adhesive and procoagulant activities of platelets.
Elevated levels of cell-derived microparticles with procoagulant activity in cocaine abusers: Association with increased thrombin generation and a prothrombotic state.
Pre-eclampsia like syndrome in pregnant rats treated with a serotonin precursor
C-reactive protein and soluble thrombomodulin: biochemical markers of maintenance of sinus rhythm at 1-year follow-up in patients with non-valvular atrial fibrillation
Diagnostic assessment of patients with inherited mucocutaneous hemorrhages (IMCH): Opening a pandora box?
Loss of platelet membrane phospholipid asymmetry in systemic lupus erythematosus: Association with disease activity and hypercoagulable state.
C-reactive protein in atrial fibrillation: Evidence for the presence of inflammation in the genesis and perpetuation of the arrhythmia
Hydralazine can prevent 5hydroxy-tryptophan-induced acute renal failure in rats.
A variant of decay accelerating factor (DAF) in Chilean natives.
Thrombin-antithrombin levels are directly associated with heart rate at entry in patients with non-valvular atrial fibrillation
Amphotericin B induces premature apoptosis in stored platelets.
Acute immune thrombocytopenia (TP) after administration of tirofiban is associated with antibodies (Abs) that recognize ligand-occupied GPIIb/IIIa.

Letter (5)

Diagnosing type 1 von Willebrand disease: good for patient's health or for doctor's prestige?: comment
Template bleeding time and PFA-100((R)) have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients - a reply to rebuttals
High plasma levels of lipoprotein(a) in uremic patients are related to markers of inflammation, and to activated, not impaired, fibrinolysis
Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis
Fast decrease of bleeding time by tranexamic acid in uremia

Review (4)

New oral anticoagulant drugs
Control of bleeding in cancer
The Level of Laboratory Testing Required for Diagnosis or Exclusion of a Platelet Function Disorder Using Platelet Aggregation and Secretion Assays
An insight into the pathophysiology of thrombosis in antiphospholipid syndrome
111
Jaime Pereira

Jefe

Hematología-Oncología

ESCUELA DE MEDICINA, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

59
Olga Panes

Technical Director/ Associated Research

Hematology-Oncology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

49
Diego Mezzano

Director

Hematology-Oncology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

22
Valeria Matus

Associate Researcher

Hematology-Oncology

P. UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

15
Marcelo Alarcón

Profesor

Bioquimica Clinica e Inmunahematologia

UNIVERSIDAD DE TALCA

Talca, Chile

15
Iván Palomo

Hematology Professor

Clinical Biochemistry and Immunohematology

UNIVERSIDAD DE TALCA

Talca, Chile

15
Eduardo Aranda

Biochemist

Hematology

P. UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

12
Monica Acevedo

Associate Professor

Division of Cardiovascular Diseases

P. UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

10
Claudia Saez

Associate Professor

Hematology-Oncology

Pontificia Universidad Católica de Chile

Santiago, Chile

7
Pamela Zúñiga

Profesor Asociado

Pediatria

Pontificia Universidad Católica de Chile

Santiago , Chile

6
Ramon Corbalan

Director

Division of Cardiovascular Diseases

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

5
Patricio Downey

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE DEPARTAMENTO DE NEFROLOGIA

SANTIAGO, Chile

3
Ada Cuevas

Médico

Nutrición Clínica

CLINICA LAS CONDES

Santiago, Chile

3
Eduardo Fuentes

Profesor Asociado

Universidad de Talca

Talca, Chile

2
Oslando Padilla

Estadístico

Salud Pública

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Juan Miquel

Full Professor

Gastroenterology

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

2
Pablo Strobel

Prrofesional de laboratorio

Facultad Ciencias Veterinarias

Universidad Austral de Chile

Valdivia, Chile

2
oscar castillo

Director Escuela

Facultad de Medicina

Universidad Finis Terrae

Santiago, Chile

2
Juan Carlos Quintana

Médico nuclear

Radiología

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Max Andresen

profesor asociado categoria ordinaria

medicina Intensiva

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

2
Carlos Ibáñez

Jefe Unidad de Adicciones

HOSPITAL CLÍNICO , UNIVERSIDAD DE CHILE

Saltiago, Chile

1
Julio Caballero

Full Professor

Departamento de Bioinformática

Universidad de Talca

Talca, Chile

1
Enrique Castellón

Profesor Titular. Director

Oncología Básico-Clínica

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Andres Aizman

Assitant Professor

Internal Medicine

Pontificia Universidad Católica de Chil

Santiago, Chile

1
Rafaela Erices

Postdoctorante

Ginecología y Obstetricia

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Claudio Valenzuela

CONFERENCIANTE

ESCUELA DE MEDICINA

Universidad de Talca

Talca, Chile

1
Gonzalo Farías

Profesor Asistente

Departamento de Neurología y Neurocirugía Norte y Departamento de Neurociencias

Facultad de Medicina, Universidad de Chile

Santiago, Chile

1
Luz Letelier

Jefe de Departemento

Medicina Interna

Pontificia Universidad Catolica de Chile, Facultad de Medicina

Santiago, Chile

1
Edgard Pais

Director Médico

Nefrodiálisis San Lucas

Santiago, Chile

1
Alejandro Berkovits

MEDICO

LABORATORIO CLINICO

CLINICA ALEMANA DE SANTIAGO

SANTIAGO, Chile

1
Rodrigo Moore

Profesor Asociado

Bioquímica Clínica e Inmunohematología

UNIVERSIDAD DE TALCA

Talca, Chile

1
Maria Ocaranza

Asociate Professor

Cardiovascular Diseases Division

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
maria carrasco

médico staff

Pabellones

Clinica alemana - Universidad del Desarrollo

santiago, Chile

1
Armando Rojas

Profesor Titular, Director de Laboratorio Investigaciones Biomédicas

Ciencias Preclínicas

FACULTAD DE MEDICINA, UNIVERSIDAD CATOLICA DEL MAULE

Talca, Chile

1
Alberto Leguina-Ruzzi

Junior Researcher

Physiology

Czech Academy of Science

Pr, Rep. Checa

1
Aniela Wozniak

Coordinador de Investigación

Dept Laboratorios Clínicos

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Gareth Owen

Profesor Titular

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
RENAN ORELLANA

Investigador

Ciencias Químicas y Biológicas

Universidad Bernardo O'Higgins

Santiago, Chile

1
PABLO PEREZ

Investigador Postdoctoral

Anatomía Patológica/Oncología

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Maria Hernandez

Investigador Post Doctoral

Universidad de Chile

Santiago, Chile

1
Fabián Segovia

Assistant professor

Department of Cell Biology

Universidad de Concepción

Concepción, Chile